Sex (1: male, 2: female)
age
Histology (1: squamous, 2: adenoca, 3: BAC=adenoca., 4: small cell 5: carcinoid tumor, neuroendocrine tumor, 6: rhabdomyosarcoma, 7: pulmonary intimal sarcoma 8. mucinous carcinoma 9: adenosquamous 10 large cell
newHistology (1. squamous cell, 2: adenoca. 3. small cell 4. sarcaoma, neuroendocrine, etc)
Time of diagnosis (lung cancer)
initial stage (1:0 2: IA, 3: IB 4: IIA, 5: IIB, 6: IIIA, 7: IIIB, 8: IV 9: limted, 10: extended, 999: NA)
lung surgery (1: none, 2: done)
prophylactic brain RT (1: none, 2: done)= cranial irradiation
KPS at brain diagnosis
location of brain meta (1: frontal, 2: parietal, 3: temporal, 4: occipital, 5: cerebellum, 6: basal ganglia 9: multipl e)
number of brain meta
maximal diameter of tumor (mm)
OP date
EOR (1: biopsy, 2: subtotal resection, 3: gross total resection)
previous irradiation (1: none, 2: SRS, 3: WBRT)
postop complication (1: no, 2: yes)
contents (1: ICH, 2: infarction 3: EDH)
postop neurological deficits (1: no, 2: yes)
contents (1: weakness , 2:aphasia 3. altered mentality)
expected survival (months, NA: 999)
diagnosis to brain meta surgery (time duraion)
metastasis organ 몇개인지 (at brain surgery)- brain 제외
adjuvant RT (1: no, 2: yes)
RT method (1: no RT, 2: field RT (surgical bed), 3: whole brain: 30Gy)
add SRS (1: none, 2: tumor bed, 3: other lesions)
adjuvant SRS (1: none, 2: surgical bed, 3: other lesion, 4: surgical bed + other lesion)
EGFR mutation (1: no, 2: yes)
ALK translocation, mutation (1: no, 2: yes)
TTF-1 (thyroid transcripting factor-1)
K-ras
ROS-1
PD-L1
CTX (exclude target agent) after brain surgery (1: no, 2: yes)
targeted therapy (1: none. 2: done)
number of targeted agent (사용한 targeted therapy 개수)
EGFR target agent
ALK 억제제
local recurrence-resection bed (1: no, 2: yes)
local recur time
distant recurrence, new (1: no, 2: yes)
distant recur time
PFS (local recur)
PFS (distant recur)
recurrence time
Death/alive (1: alive, 2: death)
last FU date
Death date
FU period
single vs. multiple metz
resection bed RT (RTSRS 포함)
WBRT or not
과12개월 이하, 초
NSCLC vs SCLC
stage 1 to 4
하60세 이상 이
single vs. multiple
부WBRT 여
NSCLCvsSCLC=1 (FILTER)
leptoemeningeal seeding (1: none, 2: done)
RPA class